medigraphic.com
ISSN 2007-8560 (Impreso)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2008, Número 2

<< Anterior Siguiente >>

Ortho-tips 2008; 4 (2)


Factores de riesgo en enfermedad tromboembólica venosa

Flores GMT

Idioma: Español
Referencias bibliográficas: 13
Paginas: 78-86
Archivo PDF: 89.15 Kb.


FRAGMENTO

La enfermedad tromboembólica venosa (ETV), representa un grave problema de salud pública en todo el mundo, con una incidencia de 250,000 a 2,000,000 casos por año en EUA.
La predisposición depende de factores adquiridos o hereditarios. Muchos de los factores adquiridos pueden modificarse y disminuir considerablemente la incidencia de trombosis venosa profunda (TVP) o embolia pulmonar (EP).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Haake DA, Berkman SA. Venous thromboembolic disease after hip surgery: Risk factors, prophylaxis, and diagnosis. Clin Orthop 1989; 242: 212-231.

  2. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement: An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am 1984; 66: 194-201.

  3. Watts AC, Brenkel IJ. A postal survey of current thromboprophylactic practices of consultant orthopaedic surgeons in the treatment of fracture of the hip. J Bone Joint Surg [Br] 2005; 87-B: 296-300.

  4. Morris GK, Mitchell JRA. Prevention and diagnosis of venous thrombosis in patients with hip fractures: a survey of current practice. Lancet 1976; 2: 867-72.

  5. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: FINDINGS FROM THE GLOBAL ORTHOPAEDIC REGISTRY. J Bone Joint Surg Br, Jun 2007; 89-B: 799-807.

  6. Della Valle C, Steigler D, Di Cesare PE. Thromboembolism after hip and knee arthroplasty diagnosis and treatment. J Am Acad Orthop Surg 1998; 6: 327-336.

  7. Collins R, Baigent C, Sandercock P, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988; 318(18): 1162-73.

  8. Hull RD, Raskob GE, Hirsh J. The diagnosis of clinically suspected pulmonary embolism. Practical approaches. Chest 1986; 89(5 Suppl): 417S-425S.

  9. Bergqvist D, Jendteg S, Lindgren B, Mätzsch T, Persson U. The economics of general thromboembolic prophylaxis. World J Surg 1988; 12(3): 349-55.

  10. Morrell MT, Dunnill MS. The post mortem incidence of pulmonary embolism in a hospital population. Br J Surg 1968; 55(5): 347-52.

  11. Gallus AS. Anticoagulants in the prevention of venous thromboembolism. Baillieres Clin Haematol 1990; 3(3): 651-84.

  12. Nicolaides AN, Fareed J, Kakkar AK, Breddin HK, Goldhaber SZ, Hull R, Kakkar VV, Michiels JJ, Myers K, Samama M, Sasahara A, Kalodiki E. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). International Angiology 2006; 25(2): 101-161.

  13. Pulmonary Embolism Disease: ACCP Consensus Committee on Management of Venous Thromboembolic. Chest 1998; 113: 499-504.




2020     |     www.medigraphic.com